Aphantasia Logo
Back to all research
Aphantasia Logo

Building awareness and understanding of aphantasia through research, education, and community support.

About

  • What is Aphantasia?
  • What is Hyperphantasia?
  • Take Assessment
  • Getting Started
  • Newsletter
  • About Us
  • Contact

Community

  • Premium Membership
  • Find support
  • Discussions
  • Events
  • Visualize

For Professionals

  • Overview
  • Free Introduction
  • Counselor Training
  • Educator Training
  • List Your Practice
  • Pricing & Bundles

Resources

  • Articles & Stories
  • Videos & Interviews
  • Aphantasia Course
  • FAQs

Research

  • Research Library
  • Participate in Studies
  • Recruitment Services

© 2026 Aphantasia Network. All rights reserved.

  • Terms and Conditions
  • Privacy Policy
Aphantasia Logo
Back to all research
Aphantasia Logo

Building awareness and understanding of aphantasia through research, education, and community support.

About

  • What is Aphantasia?
  • What is Hyperphantasia?
  • Take Assessment
  • Getting Started
  • Newsletter
  • About Us
  • Contact

Community

  • Premium Membership
  • Find support
  • Discussions
  • Events
  • Visualize

For Professionals

  • Overview
  • Free Introduction
  • Counselor Training
  • Educator Training
  • List Your Practice
  • Pricing & Bundles

Resources

  • Articles & Stories
  • Videos & Interviews
  • Aphantasia Course
  • FAQs

Research

  • Research Library
  • Participate in Studies
  • Recruitment Services

© 2026 Aphantasia Network. All rights reserved.

  • Terms and Conditions
  • Privacy Policy
Ask AI About This Paper
Ask AI About This Paper

The role of dopamine in visual imagery—An experimental pharmacological study

DOI: 10.1002/jnr.25262
Tags:
Measurement & Assessment
Monzel, M., Karneboge, J., & Reuter, M. (2024). The role of dopamine in visual imagery—an experimental pharmacological study. Journal of Neuroscience Research, 102(1). doi:https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.25262

Abstract

Mental imagery enables people to simulate experiences in their minds without the presence of an external stimulus. The underlying biochemical mechanisms are poorly understood but there is vague evidence that dopamine may play a significant role. A better understanding at the biochemical level could help to unravel the mechanisms of mental imagery and related phenomena such as aphantasia (= lack of voluntary mental imagery), but also opens up possibilities for interventions to enhance or restore mental imagery. To test the hypothesis that acute dopamine depletion leads to a decrease in the strength of mental imagery, N = 22 male participants will be administered an amino acid mixture containing branched‐chain amino acids (BCAAs) and tryptophan (TRP) to transiently reduce dopamine synthesis and further N = 22 male participants will receive a placebo. Plasma prolactin (PRL) levels are determined as a peripheral marker of brain dopamine function. The strength of mental imagery will be measured before and after ingestion of the BCAA/TRP mixture using the method of mental imagery priming. Additional exploratory analyses will use genetic data to investigate possible effects of variations on dopaminergic gene loci (e.g., DAT1) on dopamine levels and strength of mental imagery. The results show […].

Authors

  • Merlin Monzel30
  • Jana Karneboge4
  • Martin Reuter16

The role of dopamine in visual imagery—An experimental pharmacological study

DOI: 10.1002/jnr.25262
Tags:
Measurement & Assessment
Monzel, M., Karneboge, J., & Reuter, M. (2024). The role of dopamine in visual imagery—an experimental pharmacological study. Journal of Neuroscience Research, 102(1). doi:https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.25262

Abstract

Mental imagery enables people to simulate experiences in their minds without the presence of an external stimulus. The underlying biochemical mechanisms are poorly understood but there is vague evidence that dopamine may play a significant role. A better understanding at the biochemical level could help to unravel the mechanisms of mental imagery and related phenomena such as aphantasia (= lack of voluntary mental imagery), but also opens up possibilities for interventions to enhance or restore mental imagery. To test the hypothesis that acute dopamine depletion leads to a decrease in the strength of mental imagery, N = 22 male participants will be administered an amino acid mixture containing branched‐chain amino acids (BCAAs) and tryptophan (TRP) to transiently reduce dopamine synthesis and further N = 22 male participants will receive a placebo. Plasma prolactin (PRL) levels are determined as a peripheral marker of brain dopamine function. The strength of mental imagery will be measured before and after ingestion of the BCAA/TRP mixture using the method of mental imagery priming. Additional exploratory analyses will use genetic data to investigate possible effects of variations on dopaminergic gene loci (e.g., DAT1) on dopamine levels and strength of mental imagery. The results show […].

Authors

  • Merlin Monzel30
  • Jana Karneboge4
  • Martin Reuter16

What This Study Is About

This study explores whether dopamine—a chemical messenger in the brain often linked to reward and movement—plays a role in how vividly people can "see" images in their mind. Researchers wanted to see if lowering dopamine levels would make mental imagery (the ability to picture things in your mind) less clear or intense.

How They Studied It

The researchers conducted a controlled experiment with 44 participants who initially reported having clear mental imagery. The group was split in two: half drank a special mixture of amino acids designed to temporarily lower their dopamine levels, while the other half drank a placebo (a harmless drink with no effect). To measure the results, participants completed the Vividness of Visual Imagery Questionnaire (VVIQ) and a "binocular rivalry" task—an objective test where imagining a specific pattern can influence which of two different images the brain chooses to see through 3D glasses.

What They Found

The study found that lowering dopamine significantly reduced the vividness of mental imagery. Participants who drank the dopamine-lowering mixture reported lower scores on imagery questionnaires compared to the placebo group. More importantly, their performance on the objective binocular rivalry test also dropped, suggesting that their "mind's eye" had become physically weaker. This suggests that dopamine is a key biological ingredient for creating voluntary mental images.

What This Might Mean

These findings suggest that aphantasia—the inability to visualize—might be linked to how the brain processes dopamine. If low dopamine reduces imagery vividness, it is possible that some forms of aphantasia are related to naturally lower dopamine activity in specific brain regions. However, because this study only temporarily lowered dopamine in people who could already visualize, more research is needed to see if increasing dopamine could help those with aphantasia.

One Interesting Detail

The researchers noted that dopamine's role in imagery might explain why people with Parkinson’s disease (which involves low dopamine) often report less vivid dreams, while the medication used to treat them can sometimes cause vivid hallucinations.
This summary was generated by AI and may contain errors. Always refer to the original paper for accuracy.
Aphantasia Logo
Most-Cited Researchers
Top 10 researchers by number of papers published in Aphantasia
1

Joel Pearson

35
2

Merlin Monzel

30
3

Adam Zeman

20
4

Rebecca Keogh

17
5

Martin Reuter

16
6

Juha Silvanto

14
7

Paolo Bartolomeo

11
8

Carla Dance

10
9

Jianghao Liu

9
10

Fraser Milton

9
Recruit the largest aphantasia cohort on earth

97.8K+ users & subscribers across the imagery spectrum, plus 1.5M+ survey responses in our dataset. Skip the recruitment bottleneck and run your study with the community we've built for a decade.

Partner with us